NDC 0944-0495-06 - Flexbumin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0944-0495
- Requested NDC
- 0944-0495-06
- Package NDCs from labels
- 0944-0495-06, 0944-0495-05
- Manufacturer
- Takeda Pharmaceuticals America, Inc. | BAXALTA INCORPORATED | Baxalta US Inc.
- Effective date
- 2024-12-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Flexbumin | Takeda Pharmaceuticals America, Inc. | BAXALTA INCORPORATED | Baxalta US Inc. | 2024-12-18 | PLASMA DERIVATIVE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0944-0495-05 | Flexbumin | 2 in 1 CARTON | INJECTION, SOLUTION | 2 | 14 | |
| 0944-0495-06 | Flexbumin | 250 mL in 1 BAG | INJECTION, SOLUTION | 250 | 14 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0944-0495-05 | ML - Milliliter | 0944-0495 | e6b5163d-2d6e-48d4-82f5-00370a448dea | 1 | 2014-11-05 |
| 0944-0495-06 | ML - Milliliter | 0944-0495 | 73e9eb05-b979-44c1-b952-01d90fea11fb | 1 | 2024-01-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ALBUMIN HUMAN | ACTIVE INGREDIENT | ZIF514RVZR | FLEXBUMIN (ALBUMIN HUMAN) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 1 | |
| ALBUMIN HUMAN | ACTIVE MOIETY | ZIF514RVZR | FLEXBUMIN (ALBUMIN HUMAN) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 1 | |
| SODIUM ACETYLTRYPTOPHANATE | INACTIVE INGREDIENT | 3EN9H0M2FX | FLEXBUMIN (ALBUMIN HUMAN) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 1 | |
| SODIUM CAPRYLATE | INACTIVE INGREDIENT | 9XTM81VK2B | FLEXBUMIN (ALBUMIN HUMAN) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Multiple Electrolytes pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | Fresenius Kabi USA, LLC | 84221110-b3f1-42f4-800c-ad1d3b330e9e | 2022-11-10 | Warnings, Adverse reactions | 4550K0SC9B |
| Multiple Electrolytes pH 5.5 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | Fresenius Kabi USA, LLC | cf1f5f15-d31d-4a02-8f7e-b289d5ad4b5c | 2022-11-10 | Warnings, Adverse reactions | 4550K0SC9B |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | e4f06c0b-7cb1-49c9-97a4-2cfc21298495 | 2021-11-16 | Warnings, Adverse reactions | 4550K0SC9B |
| Solucion InterSol | SOLUCION ADITIVA PARA PLAQUETAS 3 | Fenwal, Inc. | d5eaf5f4-67d3-4475-af9a-f5b0f882f5d1 | 2021-10-04 | Warnings, Adverse reactions | 4550K0SC9B |
| CLINIMIX E | LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DIBASIC POTASSIUM PHOSPHATE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, DEXTROSE | Baxter Healthcare Company | 8469d6fb-d6ef-476f-8cc3-0905192de0a8 | 2021-04-13 | Warnings, Adverse reactions | 4550K0SC9B |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | a00c4a93-cde2-4753-81f7-0d6fee9fb690 | 2020-10-20 | Warnings, Adverse reactions | 4550K0SC9B |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2020-05-14 | Warnings, Adverse reactions | 4550K0SC9B |
| Plasma-Lyte A | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | Baxter Healthcare Corporation | 6ec9e61c-2c26-402f-8604-f446b2e34058 | 2019-08-05 | Warnings, Adverse reactions | 4550K0SC9B |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.